Kyverna Therapeutics
KYTX
#8026
Rank
NZ$0.32 B
Marketcap
$7.41
Share price
-9.38%
Change (1 day)
N/A
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$50.46 Million

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are NZ$50.46 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$0.22 B15.08%
2021-12-31NZ$0.19 B